Cargando…

New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?

New recommendations from the Global Initiative for Asthma (GINA) were released in a pocket guide form on April 12, 2019. These recommendations provide very important changes to the management of asthma, especially regarding the treatment of intermittent and mild asthma. Due to safety concerns, GINA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuprys-Lipinska, Izabela, Kolacinska-Flont, Marta, Kuna, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268540/ https://www.ncbi.nlm.nih.gov/pubmed/32514334 http://dx.doi.org/10.1186/s13601-020-00316-z

Ejemplares similares

Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2015)

Loss of asthma control after cessation of omalizumab treatment: real life data
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2014)

Good outcomes of pregnancy in two cases of women treated with omalizumab due to the severe asthma
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2013)

Omalizumab in pregnant women treated due to severe asthma: two case reports of good outcomes of pregnancies
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2014)

Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2018)

Diagnosis and management of asthma – Statement on the 2015 GINA Guidelines
por: Horak, Fritz, et al.
Publicado: (2016)

Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2016)

Symptom versus exacerbation control: an evolution in GINA guidelines?
por: Latorre, Manuela, et al.
Publicado: (2023)

Prevalence, risk factors and underdiagnosis of asthma in the general population aged over 60 years
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2019)

Implementation of GINA guidelines in asthma management by primary care physicians in Vietnam
por: Nguyen, Vinh Nhu, et al.
Publicado: (2017)

The position paper of the Polish Society of Allergology on climate changes, natural disasters and allergy and asthma
por: Pałczyński, Cezary, et al.
Publicado: (2018)

Effectiveness and adverse events of plasmapheresis and immunoglobulin G infusion in patient with resistant chronic urticaria and angioedema - a case report
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2015)

It is time to change the way we manage mild asthma: an update in GINA 2019
por: Muneswarao, Jaya, et al.
Publicado: (2019)

Are the Global Initiative for Asthma (GINA) Guidelines Being Correctly Used to Diagnose Severe Asthma in the UAE?
por: Abuzakouk, Mohamed, et al.
Publicado: (2020)

A comparison of cyst wall curettage and en bloc excision in the treatment of aneurysmal bone cysts
por: Flont, Pawel, et al.
Publicado: (2013)

287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
por: Tworek, Damian, et al.
Publicado: (2012)

Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma
por: Kupczyk, Maciej, et al.
Publicado: (2019)

Classification of asthma according to revised 2006 GINA: Evolution from severity to control
por: Koshak, Emad A.
Publicado: (2007)

Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2014)

The GINA asthma strategy report: what’s new for primary care?
por: Reddel, Helen K, et al.
Publicado: (2015)

Two cheers for GINA?
por: McGuire, Amy L, et al.
Publicado: (2009)

Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the Guidelines
por: Bousquet, Jean, et al.
Publicado: (2010)

The Step Further to Understand the Role of Cytosolic Phospholipase A(2) Alpha and Group X Secretory Phospholipase A(2) in Allergic Inflammation: Pilot Study
por: Pniewska, Ewa, et al.
Publicado: (2014)

A summary of the new GINA strategy: a roadmap to asthma control
por: Reddel, Helen K., et al.
Publicado: (2015)

Expression of Transcript Variants of PTGS1 and PTGS2 Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps
por: Pietruszewska, Wioletta, et al.
Publicado: (2021)

Asthma in pregnancy: association of asthma control test (ACT) with clinical management by the global initiative for asthma (GINA)
por: Araujo, Georgia, et al.
Publicado: (2015)

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy
por: Brusselle, Guy, et al.
Publicado: (2017)

The correlation between the bronchial hyperresponsiveness to methacholine and asthma like symptoms by GINA questionnaires for the diagnosis of asthma
por: Lim, So Yeon, et al.
Publicado: (2014)

Gina DeNicola: In vivo veritas
por: Morgado-Palacin, Lucia
Publicado: (2023)

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy
por: Cruz, Álvaro A., et al.
Publicado: (2021)

Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
por: Levy, Mark L., et al.
Publicado: (2023)

Use of Global initiative for asthma (GINA) guidelines in asthma management among paediatric residents in a Sub Saharan African country: a cross-sectional descriptive study
por: Chikaodinaka Ayuk, Adaeze, et al.
Publicado: (2017)

Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany
por: Bergmann, Karl-Christian, et al.
Publicado: (2022)

Expression of cPLA(2)γ mRNA and protein differs the response of PBMC from severe and non-severe asthmatics to bacterial lipopolysaccharide and house dust mite allergen
por: Pniewska-Dawidczyk, Ewa, et al.
Publicado: (2021)

Disparate impacts and GINA: Congress's unfinished business
por: Wagner, Jennifer K
Publicado: (2019)

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021)

Intermittent to Mild Asthma: The Need for Continued Treatment
por: Yoon, Ho Joo
Publicado: (2013)

Small Airways: The “Silent Zone” of 2021 GINA Report?
por: Cottini, Marcello, et al.
Publicado: (2022)

Intermittent and mild persistent asthma: how therapy has changed
por: Di Cicco, Maria Elisa, et al.
Publicado: (2021)

Improvement in symptoms and pulmonary function of asthmatic patients due to their treatment according to the Global Strategy for Asthma Management (GINA)
por: Boskabady, Mohammad H, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_4hk8kqc0btm0acctu5el1ltkem